Featured Articles
-
The Gig Economy And GxP Auditing In 2024
11/2/2023
See how this unique GxP auditing approach can ensure that vendors are complying with all rules and regulations quickly and efficiently, benefiting sponsors and auditors alike.
-
3 Enrollment Barriers And How To Overcome Them
11/2/2023
Read along as this author sheds light on the top three common barriers to clinical trial enrollment and offers a fundamental framework for overcoming these challenges.
-
Selecting The Right Pharmacovigilance Vendor
10/3/2023
Delve into several key benefits of entrusting pharmacovigilance needs to a qualified vendor, from economic efficiency and access to expertise to ensuring regulatory compliance and patient safety, and more.
-
Building Strong Relationships With Patient Advocacy Organizations
10/3/2023
When engaged with, patient advocacy organizations can be an invaluable resource. Delve into various strategies for establishing trust and long-lasting relationships with PAOs.
-
3 Simple Tips for Preventing Clinical Trial Fraud
9/6/2023
Clinical trial fraud is a prevalent issue that demands attention. Review several strategies for upholding due diligence and substantially reducing the risk of fraud in clinical trials.
-
5 Benefits Of Outsourcing Your Next Study To 2 CROs
8/31/2023
Examine the merits associated with the strategic pairing of two distinct contract resource organizations: one focused on clinical requirements and the other specialized in biometrics.
-
How To Evaluate & Select The Right eQMS For Your Needs
7/17/2023
Learn how partnering with an experienced functional service provider can help evaluate, implement, and integrate a QMS system while allowing core teams to stay on task.
-
Clinical Research Safety: Ensuring Participant Protections
7/17/2023
Gain a better understanding of how trials are designed and carried out with patient safety at the top of mind.
-
Understanding When And How To Terminate Your CRO
7/17/2023
Ever think about terminating your CRO contract? Delve into the reasons why you might, the potential implications, and the strategies for a successful exit and transition process.
-
FDA Releases Updated Draft Guidance On Decentralized Clinical Trials
6/12/2023
Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.